Skip to content

Effect of Bhumyamalaki Swarasa and Nisha Amalaki Churna in the management of Metabolic Syndrome w.s.r. Medodushti

Comparative study to evaluate the efficacy of Bhumyamalaki Swarasa and Nisha Amalaki Churna in the management of Metabolic Syndrome w.s.r. Medodushti- A randomized controlled open clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079572
Enrollment
52
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E889- Metabolic disorder, unspecified

Interventions

None listed

Sponsors

Chaudhary Brahm Prakash Ayurved Charak Sansthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients who met the criteria given by NCEP ATP III Waist circumference over 40 inches in men or 35 inches in women Blood pressure over 130/85 mm of Hg Fasting triglyceride level over 150mg/dl Fasting high density lipoprotein cholesterol level less than 40mg/dl in men or 50mg/dl in women Fasting blood sugar over 100mg/dl 2 Homeostatic Model Assesment Insulin Resistant HOMA-IR Score less than 2.9 3 Patients having age between 21 to 60 years with irrespective of gender 4 Subjects who are able to take medicine orally 5 Subjects who are willing to sign the informed consent

Exclusion criteria

Exclusion criteria: 1 Fasting blood sugar more than 140 mg/dl 2 Blood Pressure over more than 140/90 mm of Hg 3 Type I and Type II Diabetes mellitus with major complications such as Heart Disease and Stroke Diabetic Nephropathy,Diabetic Retinopathy,Peripheral Neuropathy 4 Systemic illness such as tuberculosis, carcinoma and patient having the history of Myocardial infarction or unstable angina 5 Patient having major renal or liver disorders 6 Lactating mothers and pregnant females 7 Substance abusers such as alcohol 8 Subjects who are registered in any other research project

Design outcomes

Primary

MeasureTime frame
Reduction in HOMA-IR ScoreTimepoint: Day 0 and Day 90

Secondary

MeasureTime frame
Reduction in the levels of Sr. Triglyceride Sr. HDL-C HbA1c Blood Pressure Waist Circumference along with improvement in the clinical features of Medodushti Dhatusamyata and VikaropshamanTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Yogesh Kumar Pandey

Chaudhary Brahm Prakash Ayurved Charak Sansthan

dryogeshpandey@gmail.com9013858523

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026